Allergic Rhinitis Clinical Trial
Official title:
Effects of Chinese Herbal Medicine for Treatment of Allergic Rhinitis: A Randomized Controlled Trial
The aim of this study is to test and compare the effectiveness between three groups -
Cure-Allergic Rhinitis Syrup (CS), Yuk ping fung San (YS) and placebo groups - of
adolescents (nursing students) with Allergic Rhinitis (AR) in improving their symptoms of
AR, body constitution pattern and health-related quality of life.
• The hypothesis are to test the effectiveness of the CS treatment on these students' AR
symptoms and quality of life at immediately, one month and two months after completion of
the 4-week intervention, when compared with the YS treatment and placebo group.
1. Cure-Allergic Rhinitis Syrup (CS) group will show significantly reduction of AR
symptoms over the 2-month follow-up, when compared to those in YS and placebo groups.
2. CS group will indicate a healthier body constitution pattern over the follow-up, when
compared to those with YS and placebo group.
3. CS group will indicate significantly greater improvement of their quality of life over
2-month follow-up, when compared to those with YS and placebo group.
Background
- Rhinitis (AR) is one of the most concerned public health problems worldwide, resulting
from an inflammation of nasal membranes.
- Nursing students is one of the high risk groups, particularly when performing clinical
practicum in hospitals in which they would contact with multiple allergens such as
micro-organisms, detergents, chemical agents, and frequently used powdered latex
gloves. More than 10% of these adolescents would present consistent AR symptoms such as
nasal congestion, sneezing and sleep problems and In turn, these symptoms could affect
their quality of life and academic performance.
- Non-compliance to medication or refusals to medical advice was common due to lack of
efficacy, side effects, fear of being habit-forming, and/or expensive medical costs;
and thus many preferred an alternative therapy for improved symptoms and bodily
condition, and even full recovery.
- Chinese medicine treats the disease from the root, which is a complementary and
alternative approach for holistic convalescence by changing unhealthy body constitution
(health status) to healthy. However, little scientific evidence has been established
for the treatment of AR with Chinese herbal medicine.
- This study aims to test the effects of two alternative treatments of Chinese herbal
medicine, including Cure-Allergic Rhinitis Syrup (CS) and Yuk ping fung San, when
compared with a placebo (i.e., wheat syrup with similar taste and smell) group, in
reducing university nursing students' AR symptom severity and improving their quality
of life and body constitution.
Methodology
- A double-blind randomized controlled trial with repeated-measures, three parallel
groups design is adopted.
- Assessment and follow-ups would be taken place in an Integrative Health Clinic of The
University under study.
- Stratified random sampling method in terms of the students' years of illness onset and
gender has been used to allocate the subjects into one of the three study groups.
- Participants, assessor and researcher are concealed and blinded to the random group
allocation, which would be performed by an independent clinic nurse.
- In order to maintain complete blinding, a clinic nurse will also administer the herbal
medicine and keep the name list locked, and thus being confidential.
- Participants would be recruited from all of five full-time undergraduate nursing
programs in School of Nursing of The University. After their eligibility for inclusion
checked and baseline measurement performed with informed consent obtained, the
participants would be grouped in terms of duration of the illness (0-2 years, 2-5 years
and 5 or above years) and gender and then each would draw one labeled card from an
opaque envelope (1=CS, 2=YS and 3=Placebo) from the clinic nurse to allocate them into
one of the three groups.
- Quality of life and symptom severity would be measured with self-administered
questionnaires, and body constitution assessment would be performed by an Traditional
Chinese medicine (TCM) practitioner, at baseline and immediately, one-month and
three-month after the 4-week intervention.
Sampling
- All full-time nursing students in The University under study who met the inclusion
criteria and voluntary to participate in this study are the potential subjects.
- Sample size calculation has been calculated in the basis of similar Chinese herbal
medicine effects in improving AR symptoms (primary outcome) in previous studies. Total
sample size is 195 (n=65 per group) using G-Power based on the effect sizes (0.45) of
two similar recent studies (Jung, 2011; Yang, 2010). Taking account of about 20%
drop-outs, the estimated sample size becomes 234, thus 78 participants in each group.
Intervention
- Cure-Allergic Rhinitis Syrup (CS) and Yuk ping fung San (YS) are adopted as the two
alternative treatments to be tested in this study, while the placebo group will be the
controls in this study.
- Medication will be produced and provided by the researcher. CS contains 12 Chinese
herbal medicines in one formula, combining 3 classical ancient formula of herbal
medicine that are commonly used to enhance healthy body constitution. YS contains 6
herbal medicines, which are commonly used for AR treatment, while the placebo contains
wheat powder, sugar and spicy taste of food (ginger).
- Boiling methods for CS and YS are the same, in which the herbal medicines will be
boiled with 2000 ml of water for two hours after cleansing to about 500 ml herbal
concoction.
- Participants would be asked to take 20 ml per dosage on each day, by diluting two
spoons with a half cup of water either in the morning or at night, at their
convenience.
- One bottle for two-week dosage would be offered after the first assessment at
recruitment; and another bottle for the remaining 2-week dosage would be given during
the first follow-up by the end of 2nd week (Interim assessment). Each participant would
have to take in total of four weeks herbal medicine.
Ethical issues
- Ethical approval of this study will be obtained from the Human Subjects Research Ethics
Sub-committee of The Hong Kong Polytechnic University.
- Written informed consent will be obtained from the respondents to show their
willingness of participation. In order to enhance full understanding of the study
before participation, an information sheet to describe in more details about the aim
and procedure of the study will be given with explanations before signing the written
consent.
- Study data and participant identity are kept anonymous and confidential. Data collected
are limited in access by the researcher and clinic nurse for study purpose only. The
data will be destroyed after completion of the study and thesis writing.
- Precaution of adverse effects would be taken on the herbal medicine selection
(double-checked by an independent TCM practitioner), medicine formation (agreed by at
least two TCM practitioners), time of boiling, and interim assessment (by one TCM
practitioner) and weekly or bi-weekly face-to-face or telephone follow-ups (by the
researcher). Students are reminded of reporting any discomfort and asking questions
about the illness and the study. They are given the contact telephone of the researcher
and would be referred to Western medicine or TCM practitioner for follow-up, as needed.
- All herbal medicine items should be within normal and recommended dosage. Any toxic
effect of the herbal medicines used is reduced by long boiling and minimal dosage.
- Before random group allocation, all participants are assessed and confirmed with the
body constitution pattern(s) by one TCM practitioner and history of allergy to herbal
medicines, particularly those items adopted in the study, will be checked. Those with
such allergies, inappropriate body constitution for the herbal medicines used, or very
poor body condition, would be excluded.
- Monitoring of exceptional allergy such as skin rash and related discomforts would be
performed over the first 2 weeks of syrup intake. At the end of the 1st and 3rd week of
intervention, the researcher would phone up each participant to ask about any concern
or discomfort experienced.
- Monitoring the health parameters such as body temperature, blood pressure, pulse rate,
respiratory rate, and urine for routine testing to assess and understand the
participants' health condition and detect possible adverse effect of herbal medicines
during interim assessment (2nd week of intervention).
- Although very low risk for adverse events (<0.1%), the researcher would terminate the
herbal medicine used and ask the participant to attend Accident and Emergency
Department immediately if any found such as serious allergy, skin rash or any illness
such as fever or systemic infection, which might be related to signs of over
reinforcement of Yang inside the body.
- The TCM practitioner will also monitor any uncommon effects on renal and liver
functions such as diarrhea, urinary tract infection, pain, and skin rash in the 2nd and
4th week assessments.
Instruments
- Constitution in Chinese Medicine Questionnaire
o 60 items of Constitution in Chinese Medicine Questionnaire can assess the
participants' body constitution.
- Quality of life and symptom severity
- The 28-item Rhino-conjunctivitis Quality of Life Questionnaire is adopted to
evaluate the participants' level of quality of life; and
- The same questionnaire is also used for assessing their symptoms severity.
- Objective assessment of nasal symptoms
- Peak Nasal Inspiration Flow Meter will be adopted to monitor the nasal symptom
(blockage)
- Demographic and other clinical information Pilot Study
- Fifteen participants (i.e. five nursing students in each of three study groups) would
be recruited for a pilot study. The pilot study is conducted with the same procedure of
TCM assessment, and herbal medicines used.
- Data collection with all the questionnaires, health assessment, follow-ups and data
analysis will be performed similar to the main study.
- Purposes of the pilot study are to test the feasibility and procedure of the study,
evaluate the validity and reliability of the questionnaires, examine any possible
difficulty in sample recruitment and data collection, as well as check the estimated
sample size used in the main study. Very minor amendments or modifications have been
made on the procedure of the main study according to its results.
Data Collection
- Data collection would be performed at four time points: baseline measurement (Time 1)
at recruitment and three post-tests (Times 2-4) (immediately, and 1-month and 3-month
following the interventions).
- Baseline assessment would be done to determine the eligibility for participant
enrolment (making diagnosis of AR and differentiating their body constitution) and
performing baseline measurements (mainly symptom severity, quality of life and body
constitution) for the study. After 2-week interim assessment and 4-week intervention,
subsequent three post-tests would be performed using the same sets of questionnaires
for evaluation of treatment effect and comparison between and within groups.
- All assessments and data collection procedures would be performed in the Integrated
Health Clinic, the participants will self-administer the study questionnaires, be
assessed by the same TCM practitioner on body constitution and perform other health
assessments such as vital signs and urine testing.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05080322 -
Efficacy and Safety of On-demand and Continuous Administration of Nasal Spray in the Treatment of Allergic Rhinitis
|
Phase 4 | |
Recruiting |
NCT06028490 -
A Study of IL4Rα Monoclonal Antibody in Patients With Uncontrolled Seasonal Allergic Rhinitis.
|
Phase 2 | |
Completed |
NCT04388358 -
Traditional Chinese Medicine for the Treatment of Perennial Allergic Rhinitis on Gut Microbiota and Immune-modulation
|
N/A | |
Recruiting |
NCT04202263 -
Assessment of Suppression of Cutaneous Allergic Responses and Pruritis by Topical Minocycline
|
Phase 2 | |
Completed |
NCT04078009 -
Standardising Nasal Allergen Challenge in Adult With Hay Fever
|
N/A | |
Completed |
NCT03644680 -
Changes in Adaptive Immune Responses and Effector Cell Responses Upon Nasal Allergen Exposure - a Pilot Study
|
N/A | |
Completed |
NCT04541004 -
Adolescent Mite Allergy Safety Evaluation
|
Phase 3 | |
Recruiting |
NCT05378594 -
HDM and Silver Birch NAC Standardisation
|
N/A | |
Not yet recruiting |
NCT05684380 -
Efficacy and Safety of MAZ-101 in the Treatment of Persistent Allergic Rhinitis (PER)
|
Phase 3 | |
Completed |
NCT02910401 -
Clinical Response to Rhinovirus Challenge
|
Phase 2 | |
Completed |
NCT02943720 -
ATIBAR - Efficacy and Safety of Two Doses of AllerT in Patients Allergic to Birch Pollen
|
Phase 2 | |
Not yet recruiting |
NCT01014325 -
Safety and Efficacy Study With Allergen Extracts of House Dust Mites for Specific Sublingual Immunotherapy
|
Phase 3 | |
Completed |
NCT02556801 -
Efficacy and Safety of SUBLIVAC Phleum for Immunotherapy of Grass Pollen-Allergy
|
Phase 2 | |
Not yet recruiting |
NCT02233426 -
Effect of Hypertonic Solutions on Allergic Rhinitis Patients
|
N/A | |
Completed |
NCT02352168 -
Airway Inflammation in Children With Allergic Rhinitis and Intervention
|
N/A | |
Completed |
NCT01946035 -
Alpha-Blockers in Allergic Rhinitis (MAN 01)
|
Phase 4 | |
Completed |
NCT01918956 -
PURETHAL Birch RUSH Study
|
Phase 4 | |
Completed |
NCT01682070 -
SUBLIVAC FIX Phleum Pratense DT/DRF
|
Phase 2 | |
Recruiting |
NCT01454492 -
The Relationship Between Allergic Rhinitis and Geographic Tongue
|
N/A | |
Completed |
NCT01439815 -
An Allergen BioCube (ABC) Study Evaluating the Efficacy of Fluticasone Propionate Nasal Spray Compared to Placebo
|
Phase 4 |